• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胡椒碱抑制结核分枝杆菌假定多药外排泵 Rv1258c。

Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.

机构信息

Clinical Microbiology Division, Indian Institute of Integrative Medicine (CSIR), Canal Road, Jammu 180001, India.

出版信息

J Antimicrob Chemother. 2010 Aug;65(8):1694-701. doi: 10.1093/jac/dkq186. Epub 2010 Jun 4.

DOI:10.1093/jac/dkq186
PMID:20525733
Abstract

OBJECTIVES

To evaluate the role of piperine as an inhibitor of Rv1258c of Mycobacterium tuberculosis.

METHODS

Rifampicin, in combination with piperine, was tested against M. tuberculosis H37Rv and rifampicin-resistant (rif(r)) M. tuberculosis. A laboratory-generated rifampicin-resistant mutant (rif(r)) of M. tuberculosis was tested for drug susceptibility and the expression level of the putative efflux protein (Rv1258c) by real-time PCR. The three-dimensional (3D) structure of Rv1258c was also predicted using an in silico approach.

RESULTS

In the present study, rifampicin in combination with piperine, a trans-trans isomer of 1-piperoyl-piperidine, reduced the MIC and mutation prevention concentration (MPC) of rifampicin for M. tuberculosis H37Rv, including multidrug-resistant (MDR) M. tuberculosis and clinical isolates. Moreover, piperine effectively enhanced the bactericidal activity of rifampicin in time-kill studies and also significantly extended its post-antibiotic effect (PAE). In the presence of rifampicin, M. tuberculosis rif(r) showed a 3.6-fold overexpression of Rv1258c. The 3D structure of Rv1258c, using in silico modelling, was analysed to elucidate the binding of piperine to the active site.

CONCLUSIONS

The results of this study are suggestive of piperine's involvement in the inhibition of clinically overexpressed mycobacterial putative efflux protein (Rv1258c). Piperine may be useful in augmenting the antimycobacterial activity of rifampicin in a clinical setting.

摘要

目的

评估胡椒碱作为结核分枝杆菌 Rv1258c 抑制剂的作用。

方法

用利福平联合胡椒碱对结核分枝杆菌 H37Rv 及利福平耐药(rif(r))结核分枝杆菌进行检测。采用实验室生成的结核分枝杆菌 rif(r)耐药突变株进行药物敏感性检测和实时 PCR 检测推测外排蛋白(Rv1258c)的表达水平。还采用计算方法预测 Rv1258c 的三维(3D)结构。

结果

在本研究中,利福平联合胡椒碱(1-哌啶酰基-哌啶的反-反式异构体)降低了利福平对结核分枝杆菌 H37Rv 的 MIC 和防突变浓度(MPC),包括耐多药(MDR)结核分枝杆菌和临床分离株。此外,胡椒碱在时间杀伤研究中有效增强了利福平的杀菌活性,还显著延长了其抗生素后效应(PAE)。在利福平存在的情况下,结核分枝杆菌 rif(r) 中 Rv1258c 的表达水平增加了 3.6 倍。使用计算建模分析了 Rv1258c 的 3D 结构,以阐明胡椒碱与活性位点的结合。

结论

本研究结果提示胡椒碱可能参与抑制临床过表达的分枝杆菌假定外排蛋白(Rv1258c)。胡椒碱可能有助于增强利福平在临床环境中的抗分枝杆菌活性。

相似文献

1
Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.胡椒碱抑制结核分枝杆菌假定多药外排泵 Rv1258c。
J Antimicrob Chemother. 2010 Aug;65(8):1694-701. doi: 10.1093/jac/dkq186. Epub 2010 Jun 4.
2
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.结核分枝杆菌多药外排泵蛋白 Rv1258c 的分子建模与模拟研究。
PLoS One. 2018 Nov 26;13(11):e0207605. doi: 10.1371/journal.pone.0207605. eCollection 2018.
3
In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.胡椒碱与抗结核药物在结核分枝杆菌中的体外联合活性。
Tuberculosis (Edinb). 2018 Jul;111:35-40. doi: 10.1016/j.tube.2018.05.006. Epub 2018 May 14.
4
Rescue of streptomycin activity by piperine in .胡椒碱对链霉素活性的挽救作用。
Future Microbiol. 2021 Jun;16:623-633. doi: 10.2217/fmb-2020-0124. Epub 2021 Jun 8.
5
Protective efficacy of piperine against Mycobacterium tuberculosis.胡椒碱对结核分枝杆菌的保护效力。
Tuberculosis (Edinb). 2014 Jul;94(4):389-96. doi: 10.1016/j.tube.2014.04.007. Epub 2014 May 9.
6
Possible Binding of Piperine in Mycobacterium tuberculosis RNA Polymerase and Rifampin Synergism.胡椒碱可能与结核分枝杆菌 RNA 聚合酶结合并增强利福平的协同作用。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.02520-18. Print 2019 Nov.
7
Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c.合成新的维拉帕米类似物,并与利福平联合评估其对结核分枝杆菌的作用,以及在流出蛋白 Rv1258c 结合部位的分子对接研究。
Bioorg Med Chem Lett. 2014 Jul 15;24(14):2985-90. doi: 10.1016/j.bmcl.2014.05.022. Epub 2014 May 16.
8
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.胡椒碱的新型结构类似物作为金黄色葡萄球菌NorA外排泵的抑制剂
J Antimicrob Chemother. 2008 Jun;61(6):1270-6. doi: 10.1093/jac/dkn088. Epub 2008 Mar 10.
9
Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR.通过实时逆转录聚合酶链反应评估临床分离株结核分枝杆菌中外排泵基因的表达。
Microb Drug Resist. 2008 Mar;14(1):7-11. doi: 10.1089/mdr.2008.0772.
10
Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.10 种外排泵基因在耐多药和广泛耐药结核分枝杆菌临床分离株中的表达分析。
J Glob Antimicrob Resist. 2019 Jun;17:201-208. doi: 10.1016/j.jgar.2019.01.003. Epub 2019 Jan 14.

引用本文的文献

1
Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis.没食子酸对耐多药结核分枝杆菌的杀菌活性
Arch Microbiol. 2025 Aug 11;207(9):218. doi: 10.1007/s00203-025-04422-z.
2
S292L mutation in Rv1258c efflux pump drives pyrazinamide efflux and a novel inhibitor designed for co-therapy to improve MDR-TB treatment outcomes.Rv1258c外排泵中的S292L突变驱动吡嗪酰胺外排,并且一种设计用于联合治疗的新型抑制剂可改善耐多药结核病的治疗效果。
World J Microbiol Biotechnol. 2025 Aug 7;41(8):300. doi: 10.1007/s11274-025-04510-8.
3
Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance.
细菌外排泵抑制剂可降低抗生素耐药性。
Pharmaceutics. 2024 Jan 25;16(2):170. doi: 10.3390/pharmaceutics16020170.
4
Phytocompounds as potential inhibitors of mycobacterial multidrug efflux pump Rv1258c: an in silico approach.植物化合物作为分枝杆菌多药外排泵Rv1258c的潜在抑制剂:一种计算机模拟方法
AMB Express. 2024 Feb 15;14(1):25. doi: 10.1186/s13568-024-01673-9.
5
Antimicrobial resistance expansion in pathogens: a review of current mitigation strategies and advances towards innovative therapy.病原体中抗菌药物耐药性的扩展:当前缓解策略及创新疗法进展综述
JAC Antimicrob Resist. 2023 Dec 11;5(6):dlad127. doi: 10.1093/jacamr/dlad127. eCollection 2023 Dec.
6
The Art of War with : Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy.《战争的艺术》:直接靶向Mex外排泵以战略性提高抗假单胞菌药物疗效
Antibiotics (Basel). 2023 Aug 9;12(8):1304. doi: 10.3390/antibiotics12081304.
7
Deciphering the Role of -Lactamase Inhibitors, Membrane Permeabilizers and Efflux Pump Inhibitors as Emerging Targets in Antibiotic Resistance.解析β-内酰胺酶抑制剂、膜通透剂和外排泵抑制剂作为抗生素耐药性新兴靶点的作用
Indian J Microbiol. 2022 Dec;62(4):524-530. doi: 10.1007/s12088-022-01045-6. Epub 2022 Oct 28.
8
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.结核病面临的挑战:耐药性、合并感染、诊断与治疗。
Eur J Microbiol Immunol (Bp). 2022 Apr 14;12(1):1-17. doi: 10.1556/1886.2021.00021.
9
Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.靶向耐药细菌的抑制剂的药物化学
Curr Top Med Chem. 2022;22(24):1983-2028. doi: 10.2174/1568026622666220321124452.
10
Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in ATCC 19606.抑制AdeB、AceI和AmvA外排泵可恢复ATCC 19606对氯己定和苯扎氯铵的敏感性。
Front Microbiol. 2022 Feb 7;12:790263. doi: 10.3389/fmicb.2021.790263. eCollection 2021.